Dr. Gabriel A. Brooks discusses the recent FDA product labeling update for Xeloda and 5-FU which aims to highlight risks associated with DPD deficiency. According to an update from the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback